DeutschNewstral
Article
bizjournals.com on 2021-03-15 11:30
Cell and gene therapy startup raises $525M
Related news
- Chapel Hill gene therapy startup raises $50Mbizjournals.com
- Vertex-partnered gene therapy startup raises $110Mbizjournals.com
- Cell and gene therapy firm raises $170M investmentbizjournals.com
- Philadelphia gene therapy startup targeting heart disease raises $11Mbizjournals.com
- Battelle launches $200M VC-backed cell and gene therapy startup AmplifyBiobizjournals.com
- Penn cell and gene therapy spinout Interius Biotherapeutics raises $76 millionbizjournals.com
The Daily Startup: 4D Molecular Therapeutics Raises $7M for Gene Therapyblogs.wsj.com- Drive-backed gene therapy startup raises $120M to amp up biotech manufacturing in Grove Citybizjournals.com
- Stanford gene-editing startup raises $150M for sickle cell clinical trial, expansion into rare diseasesbizjournals.com
- Philadelphia cell therapy startup raises $75M, names former Biogen exec as CEObizjournals.com
- Jeff Bluestone's cell therapy startup Sonoma Biotherapeutics raises another $30M, adds key staffbizjournals.com
- MBayer launches cell and gene therapy platformmarketwatch.com
Sickle cell gene therapy gets British OKArkansas Online
Can gene therapy cure sickle cell anemia?sfbayview.com- Backed by $700M, startup led by vets of Genentech, UCSF, Juno has ambitious cell and gene therapy goalsbizjournals.com
- Philadelphia gene therapy startup plans $125M IPObizjournals.com
- Penn gene therapy spinout raises $9.2Mbizjournals.com
- Gene therapy startup Passage Bio raises $110M Series B, its second raise in less than a yearbizjournals.com
- Gene therapy developer Gyroscope Technologies raises $60.6Mbizjournals.com